Novel statistical approach for primary high-throughput screening hit selection

被引:26
作者
Yan, SF [1 ]
Asatryan, H [1 ]
Li, J [1 ]
Zhou, YY [1 ]
机构
[1] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA
关键词
D O I
10.1021/ci0502808
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The standard activity threshold-based method (the "top V approach), currently widely used in the high-throughput screening (HTS) data analysis, is ineffective at identifying good-quality hits. We have proposed a novel knowledge-based statistical approach, driven by the hidden structure-activity relationship (SAR) within a screening library, for primary hit selection. Application to an in-house ultrahigh-throughput screening (uHTS) campaign has demonstrated it call directly identify active scaffolds containing valuable SAR information with a greatly improved confirmation rate compared to the standard "top X" method (from 55% to 85%). This approach may help produce high-quality leads and expedite the hit-to-lead process in drug discovery.
引用
收藏
页码:1784 / 1790
页数:7
相关论文
共 48 条
[1]  
Alanine A, 2003, COMB CHEM HIGH T SCR, V6, P51
[2]  
[Anonymous], 2005, DAYLIGHT THEORY MANU
[3]   Integration of virtual and high-throughput screening [J].
Bajorath, F .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) :882-894
[4]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[5]   Hit and lead generation:: Beyond high-throughput screening [J].
Bleicher, KH ;
Böhm, HJ ;
Müller, K ;
Alanine, AI .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378
[6]   Improved statistical methods for hit selection in high-throughput screening [J].
Brideau, C ;
Gunter, B ;
Pikounis, B ;
Liaw, A .
JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (06) :634-647
[7]   Drug discovery: A historical perspective [J].
Drews, J .
SCIENCE, 2000, 287 (5460) :1960-1964
[8]  
Engels M F, 2001, Curr Opin Drug Discov Devel, V4, P275
[9]  
Engels MFM, 2002, J BIOMOL SCREEN, V7, P341
[10]   Leveraging process integration in early drug discovery [J].
Fay, N ;
Ullmann, D .
DRUG DISCOVERY TODAY, 2002, 7 (20) :S181-S186